Clinical trial
Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide
NCT01237314 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide
- Lead sponsor
- HealthPartners Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- May 31, 2013
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes